GQ Labs not only has a strong technical platform but also a comprehensive quality management system, strict internal standard operating procedures, implements full-process control, and information management. It can conduct Biosimilar Clinical Comparative Studies/Generic Drug Bioequivalence Studies (BE), Clinical Plasma Pharmacokinetics for Innovative Drugs, Mass Balance Studies, Metabolite Qualification and Quantification Studies, Drug-Drug Interaction Studies, etc., to meet R&D needs at the NDA stage. We can conduct the following:

• Biosimilar Clinical Comparative Studies/Generic Drug Bioequivalence Studies (BE)

• Clinical Pharmacokinetics for Innovative Drugs

• Mass Balance Studies (urine, feces)

• Metabolite Qualification and Quantification Studies (plasma, urine, feces)

• Drug-Drug Interaction Studies